Published in Ann Neurol on November 01, 1979
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry (1984) 2.68
Genetic prion disease: the EUROCJD experience. Hum Genet (2005) 2.64
Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (1982) 2.15
Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry (1988) 1.87
Genomic structure of the human prion protein gene. Am J Hum Genet (1991) 1.29
A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979. II: Epidemiology. J Neurol Neurosurg Psychiatry (1986) 1.25
The spongiform encephalopathies. J Neurol Neurosurg Psychiatry (1991) 0.98
Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry (1998) 0.89
Slow viruses and chronic disease: the contribution of epidemiology. Public Health Rep (1980) 0.76
Creutzfeldt-Jakob disease. Br Med J (Clin Res Ed) (1985) 0.75
Rapidly progressive dementia caused by spongiform encephalopathy. West J Med (1988) 0.75
Missing value estimation methods for DNA microarrays. Bioinformatics (2001) 20.84
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol (1999) 6.98
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science (1987) 6.89
Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A (1988) 6.74
Unconventional viruses and the origin and disappearance of kuru. Science (1977) 6.38
Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science (1968) 5.76
Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol (1979) 5.53
'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns. Genome Biol (2000) 5.29
Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol (1994) 5.20
Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet (1974) 4.95
Human immunodeficiency virus integration in a cell-free system. J Virol (1990) 4.48
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Experimental transmission of a Kuru-like syndrome to chimpanzees. Nature (1966) 4.29
Genetic control of natural variation in Arabidopsis glucosinolate accumulation. Plant Physiol (2001) 4.07
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science (1992) 3.93
Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet (1977) 3.58
Community clinics for leg ulcers and impact on healing. BMJ (1992) 3.28
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Real and imagined clinicopathological limits of "prion dementia". Lancet (1993) 2.96
Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev (1999) 2.96
Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A (1999) 2.76
Bias inherent in retrospective waiting-time studies: experience from a vascular surgery waiting list. CMAJ (2000) 2.74
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Transmission and passage of experimenal "kuru" to chimpanzees. Science (1967) 2.64
Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem (1993) 2.59
Detection of flaviviruses by reverse-transcriptase polymerase chain reaction. J Med Virol (1991) 2.59
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc Natl Acad Sci U S A (1989) 2.48
Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia. Nature (2005) 2.47
Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A (2000) 2.46
The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology (1987) 2.46
An extremely luminous X-ray outburst at the birth of a supernova. Nature (2008) 2.41
Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus). J Virol (1985) 2.39
Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients. Lancet (1985) 2.35
Infection-specific particle from the unconventional slow virus diseases. Science (1984) 2.34
Postural electromyographic responses in the arm and leg following galvanic vestibular stimulation in man. Exp Brain Res (1993) 2.30
Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses. J Virol (1987) 2.28
New clinical sign for orthostatic tremor. Lancet (1995) 2.25
Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry (1998) 2.22
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
Gastric cancer detection in gastric ulcer disease. Gut (1980) 2.20
The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet (1991) 2.16
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man. J Pharmacol Exp Ther (1965) 2.16
Bovine spongiform encephalopathy [corrected] Creutzfeldt-Jakob disease. BMJ (1996) 2.15
Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease). N Engl J Med (1977) 2.10
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol (1995) 2.10
Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med (1985) 2.09
HTLV-I and HTLV-III antibodies and tropical spastic paraparesis. Lancet (1985) 2.07
Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol (1986) 2.06
Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med (1986) 2.06
Supervised harvesting of expression trees. Genome Biol (2001) 2.02
Survival of scrapie virus after 3 years' interment. Lancet (1991) 1.99
Estimating cancer risk in relation to tritium exposure from routine operation of a nuclear-generating station in Pickering, Ontario. Chronic Dis Inj Can (2013) 1.97
Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J Infect Dis (1980) 1.96
Creutzfeldt-Jakob disease. The neuropathology of a transmission experiment. Brain (1969) 1.96
Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests. J Clin Microbiol (1985) 1.87
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
Chiropractic care of children with nocturnal enuresis: a prospective outcome study. J Manipulative Physiol Ther (1991) 1.85
Assessment of aggression in psychiatric admissions: semistructured interview and case note survey. BMJ (2000) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Collaborative annotation of genes and proteins between UniProtKB/Swiss-Prot and dictyBase. Database (Oxford) (2009) 1.85
Infection as the etiology of spongiform encephalopathy (Creutzfeldt-Jakob disease). Science (1969) 1.83
Slow virus diseases of the central nervous system. Am J Clin Pathol (1971) 1.83
Typing prion isoforms. Nature (1997) 1.82
Subacute spongiform virus encephalopathies. Scrapie, Kuru and Creutzfeldt-Jakob disease: a review. Am J Pathol (1972) 1.81
The familial occurrence of Creutzfeldt-Jakob disease and Alzheimer's disease. Brain (1981) 1.80
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
Prion protein expression in different species: analysis with a panel of new mAbs. Proc Natl Acad Sci U S A (1998) 1.80
Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80
Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol (1998) 1.79
Clinical signs of early osteoarthritis: reproducibility and relation to x ray changes in 541 women in the general population. Ann Rheum Dis (1991) 1.79
The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion (1998) 1.78
Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature (2000) 1.77
Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol (1975) 1.76
Kofi Annan describes new health fund for developing countries. BMJ (2001) 1.76
Ionophore toxicity in turkey breeders. Avian Dis (1983) 1.76
Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med (1985) 1.75
Acute movement disorders with bilateral basal ganglia lesions in uremia. Mov Disord (1998) 1.74
Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol (1989) 1.74
Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system. N Engl J Med (1985) 1.73
Experimental subacute spongiform virus encephalopathies in primates and other laboratory animals. Science (1973) 1.71
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group. Gastroenterology (1994) 1.70
Improvement of stiff-man syndrome with vigabatrin. Neurology (1997) 1.68